Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
-
* Corresponding authors: Lixin Zheng LZHENG@niaid.nih.gov - Michael J Lenardo lenardo@nih.gov
BMC Medical Genetics 2007, 8:41 doi:10.1186/1471-2350-8-41
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 01 Dec 2006 | |
| Reviewer's Report | Anke van den Berg | 25 Jan 2007 | |
| Reviewer's Report | Austen Worth | 07 Feb 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 09 Apr 2007 |
| Reviewer's Report | Anke van den Berg | 03 May 2007 | |
| Reviewer's Report | Austen Worth | 05 May 2007 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 01 Jun 2007 |
| Editorial acceptance | 11 Jun 2007 | ||
| Published | 02 Jul 2007 |